Jove
Visualize
Contact Us

Related Experiment Videos

Ribozymes as antiviral agents.

J Bartolomé1, I Castillo, V Carreño

  • 1Viral Hepatitis Research Foundation, Madrid, Spain.

Minerva Medica
|March 26, 2004
PubMed
Summary

This review covers ribozymes, which are RNA molecules with cleavage activity. These molecules show promise for treating viral infections like hepatitis B, C, and HIV.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coupling causality and interpretable machine learning to reveal the reaction coordinate of C-N coupling with a supramolecular Cu-calix[8]arene catalyst.

Digital discovery·2025
Same author

Neutron capture measurements for s-process nucleosynthesis: A review about CERN n_TOF developments and contributions.

The European physical journal. A, Hadrons and nuclei·2025
Same author

Metal-insulator crossover in monolayer MoS<sub>2</sub>.

Nanotechnology·2023
Same author

Late embryo mortality in Holstein cows inseminated with Holstein or Limousine frozen semen.

Reproduction in domestic animals = Zuchthygiene·2023
Same author

Complementarity between microhistological analysis and PCR-capillary electrophoresis in diet analysis of goats and cattle using faecal samples.

Animal : an international journal of animal bioscience·2021
Same author

The association of prepartum urine pH, plasma total calcium concentration at calving and postpartum diseases in Holstein dairy cattle.

Animal : an international journal of animal bioscience·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Biochemistry
  • Molecular Biology
  • RNA Therapeutics

Background:

  • Ribozymes are catalytic RNA molecules capable of specific RNA cleavage.
  • Hammerhead, hairpin, and hepatitis delta virus ribozymes are well-established therapeutic candidates.
  • These ribozymes can be engineered for targeted RNA degradation.

Purpose of the Study:

  • To review the structure and properties of key ribozyme classes.
  • To discuss advancements in ribozyme development for therapeutic applications.
  • To explore the potential of ribozymes in treating viral infections.

Main Methods:

  • Literature review of ribozyme structure and function.
  • Analysis of studies on engineered ribozymes for therapeutic targeting.
  • Synthesis of information on ribozyme applications in viral disease treatment.

Main Results:

  • Detailed structural and property analysis of hammerhead, hairpin, and HDV ribozymes.
  • Overview of engineering strategies for enhanced ribozyme efficacy and specificity.
  • Compilation of research progress in applying ribozymes against Hepatitis B, C, and HIV.

Conclusions:

  • Ribozymes represent a promising class of therapeutic agents for viral infections.
  • Continued research into ribozyme engineering is crucial for clinical translation.
  • Targeted RNA cleavage by ribozymes offers a novel treatment modality for viral diseases.

Related Experiment Videos